Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina 27599-7545, USA.
Physiol Genomics. 2010 Aug;42(3):469-79. doi: 10.1152/physiolgenomics.00070.2010. Epub 2010 Jun 15.
The extent (density and diameter) of the native (preexisting) collateral circulation in healthy tissues and the capacity of collaterals to enlarge/remodel in obstructive arterial disease are important determinants of ischemic injury. Evidence suggests that these parameters vary widely from yet-to-be-identified genetic and environmental factors. Recently, a locus on chromosome 7 was linked to less recovery of perfusion after femoral artery ligation in BALB/c and A/J versus C57BL/6 mouse strains. Moreover, evidence suggested that BALB/c and A/J share an allele(s) at this locus that is different from C57BL/6 mice. Here we tested the hypothesis that differences in collateral extent and/or remodeling underlie these findings. Compared with C57BL/6, BALB/c and A/J strains have fewer native collaterals in hindlimb (also confirmed in brain)-associated with greater reduction in perfusion immediately after femoral ligation, slower recovery of perfusion, greater hindlimb use impairment, and worse ischemia. However, A/J also differed from BALB/c in a number of these parameters, including having more robust collateral remodeling. Analysis of A/J --> C57BL/6 chromosome substitution strains confirmed that a difference in an allele(s) on chromosome 7 conferred most, but not all, of the magnitude of the differences in collateral function. Additional studies of C57BL/6 x BALB/c F1 mice demonstrated that alleles of the C57BL/6 strain exert dominance for collateral traits. Finally, negative results were obtained from studies examining a previously identified candidate gene potentially responsible for these differences-Bcl2-associated athanogene-3. These findings emphasize the major contribution of genetic background to variation in the collateral circulation and its capacity to lessen ischemia in obstructive disease.
健康组织中原生(预先存在的)侧支循环的程度(密度和直径)以及侧支在阻塞性动脉疾病中扩大/重塑的能力是缺血性损伤的重要决定因素。有证据表明,这些参数因尚未确定的遗传和环境因素而有很大差异。最近,在 BALB/c 和 A/J 与 C57BL/6 小鼠品系中,染色体 7 上的一个基因座与股动脉结扎后灌注恢复减少有关。此外,有证据表明,BALB/c 和 A/J 在此基因座上共享一个不同于 C57BL/6 小鼠的等位基因。在这里,我们检验了这样一个假设,即在侧支的程度和/或重塑方面的差异是这些发现的基础。与 C57BL/6 相比,BALB/c 和 A/J 品系的后肢(也在大脑中得到证实)的固有侧支较少,这与股动脉结扎后立即灌注减少、灌注恢复较慢、后肢使用障碍更大和缺血更严重有关。然而,A/J 在许多这些参数上也与 BALB/c 不同,包括具有更强的侧支重塑。对 A/J --> C57BL/6 染色体替换品系的分析证实,染色体 7 上的一个等位基因(或多个等位基因)差异导致了侧支功能差异的大部分,但不是全部。对 C57BL/6 x BALB/c F1 小鼠的进一步研究表明,C57BL/6 品系的等位基因对侧支特征具有显性。最后,对先前确定的候选基因(可能是导致这些差异的原因)-Bcl2 相关抗凋亡基因 3 的研究没有得到阳性结果。这些发现强调了遗传背景对侧支循环及其在阻塞性疾病中减轻缺血能力的变异的主要贡献。